Published in Transplantation on April 27, 2003
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev (2006) 1.93
Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Transplantation (2010) 1.50
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
TIS11 family proteins and their roles in posttranscriptional gene regulation. J Biomed Biotechnol (2009) 1.21
The RNA binding protein Zfp36l1 is required for normal vascularisation and post-transcriptionally regulates VEGF expression. Dev Dyn (2006) 1.17
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol (2007) 1.12
Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates. Am J Transplant (2005) 1.04
AU-rich RNA binding proteins in hematopoiesis and leukemogenesis. Blood (2011) 1.01
Role of anti-vimentin antibodies in renal transplantation. Transplantation (2014) 1.00
Interrelationships between negative energy balance (NEB) and IGF regulation in liver of lactating dairy cows. Domest Anim Endocrinol (2006) 0.99
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res (2004) 0.99
Negative energy balance alters global gene expression and immune responses in the uterus of postpartum dairy cows. Physiol Genomics (2009) 0.96
Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts. PLoS One (2012) 0.94
Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation (2004) 0.94
Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation (2005) 0.93
IFN-gamma reverses the stop signal allowing migration of antigen-specific T cells into inflammatory sites. J Immunol (2003) 0.89
Constraints on the efficacy of mucosal tolerance in treatment of human and animal arthritic diseases. Ann N Y Acad Sci (2004) 0.85
Organocatalytic asymmetric annulation of 1,3-bis(alkoxycarbonyl)buta-1,3-dienes and aldehydes. Org Lett (2013) 0.84
Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation (2002) 0.84
Sequential expression of three known protective genes in cardiac biopsies after transplantation. Transplantation (2005) 0.83
Isolation and characterization of the bovine Stearoyl-CoAdesaturase promoter and analysis of polymorphisms in the promoter region in dairy cows. Mamm Genome (2005) 0.83
ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. PLoS One (2012) 0.83
Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol (2010) 0.82
Expression of human ecto-5'-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis. Am J Transplant (2005) 0.82
A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation. Transplantation (2009) 0.81
Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody. Transplantation (2012) 0.80
Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation (2002) 0.79
Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol (2008) 0.79
Interferon-gamma and intimal hyperplasia. Circ Res (2007) 0.78
A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis. Am J Transplant (2003) 0.78
The indirect alloimmune response causes microvascular endothelial dysfunction-a possible role for alloantibody. Transplantation (2010) 0.78
Preparation of human heart for laser microdissection and proteomics. Proteomics (2004) 0.78
Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model. Transplantation (2014) 0.77
Effect of cognate human CD4+ T cell and endothelial cell interactions upon chemokine production. Transplantation (2004) 0.77
Effect of phosphorylated hsp27 on proliferation of human endothelial and smooth muscle cells. Proteomics (2009) 0.77
CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant (2003) 0.76
Management of an ABO-incompatible lung transplant. Am J Transplant (2004) 0.76
Year in school and physical activity stage of change as discriminators of variation in the physical activity correlate profile of adolescent females. J Phys Act Health (2014) 0.75
Biomarkers of rejection: are we any closer to the Philosopher's Stone? Transplantation (2009) 0.75
Letter by Rose and Dunn regarding article, "Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome". Circulation (2007) 0.75
British transplant research endangered by the Human Tissue Act. J Med Ethics (2011) 0.75
Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients. Transplantation (2007) 0.75
Solid phase assay measuring C4d deposition to determine complement fixation by HLA-specific antibodies. Methods Mol Biol (2013) 0.75
Comparison of two-dimensional echocardiographic tissue harmonic imaging and gated sestamibi single-photon emission computed tomographic left ventricular ejection fraction measurements. Am J Cardiol (2003) 0.75
Antibody alone is not a stimulator of exocytosis of Weibel-Palade bodies from human endothelial cells. Transplantation (2012) 0.75